An execution-focused investment firm specializing in commercialization and distribution-driven growth.
Geneva Private Equity invests in medical technology companies at critical inflection points. We partner with teams after clinical validation, when regulatory pathways are defined, and the primary challenge is execution. Our work centers on commercialization, distribution strategy, and operational scale.
Value Creation Framework
We support MedTech companies through hands-on execution across operations and commercialization, supported by established commercial infrastructure.
Operating Principles
Our operating principles guide commercialization-led growth, disciplined investment, and active partnership.
Geneva’s Florida lab provides established distribution access, leveraging existing distribution channels to accelerate adoption and revenue.
We invest after proof of concept and early traction, helping de-risk capital and validate product-market fit.
We work alongside founders and leadership teams, providing hands-on support that drives tangible value creation.
Operating Principles
Our operating principles guide disciplined investment, active partnership, and commercialization-led growth.
Access accelerates adoption and revenue.
Scale follows traction, not vision.
We execute alongside management teams.
Investment Criteria Snapshot
Post-clinical and early commercial medical technology companies preparing to scale.
Diagnostics, medical devices, healthcare software, and enabling medical technology
Hands-on collaboration focused on commercialization, distribution, and operational execution.
For MedTech companies approaching scale and investors seeking meaningful impact and significant returns.
Post-Clinical Advantage
Commercialization Engine
